Brain Computer Interface Market Size, Growth, Trends | Report 2022-2030
The global brain computer interface market was valued at USD 1.67 billion in 2021 and it is predicted to surpass around USD 6.36 billion by 2030 with a CAGR of 16.02% from 2022 to 2030.
Report Highlights
Brain Computer Interface (BCI) is a revolutionary technology that facilitates direct contact between peripheral electronic devices calibrating the movement and a functional brain in physically challenged people. This system records the brain signal from the sensors that are placed over the scalp or devices implanted in the brain. Compumedics, in its annual report 2021, stated that it is demonstrating strong signs of growth in the future and is returning to its normal business after the COVID-19 pandemic.
It also stated that with the post-COVID-19 trends, such as high demand for eHealth and home-based healthcare services, the company is set to share many positive announcements in 2022. Hence, the market players are now moving toward positive growth post the pandemic. The market growth is anticipated to be driven by continuous developments in medical sensors and computational biology. In addition, increasing R&D pertinent to the development of treatment options for chronic conditions, such as cerebrovascular diseases, sleep disorders, brain disorders, and fatal injuries, is further contributing to the market growth.
Furthermore, growing R&D investments and the presence of government projects, such as DECODER (European project that used BCI to detect consciousness in non-responsive patients), coupled with the rising focus of major market players on emerging economies, such as Japan and China, are expected to propel market growth over the forecast period. The ongoing technological advancements in the field of virtual reality and increasing applications of BCI in the communication, gaming, and entertainment industry are some of the key contributors to the market growth. The technology encompasses a wide array of applications designed to revolutionize the communication, automation, security, and entertainment experience.
Scope of The Report
| Report Coverage | Details |
| Market Size in 2021 | USD 1.67 billion |
| Revenue Forecast by 2030 | USD 6.36 billion |
| Growth rate from 2022 to 2030 | CAGR of 16.02% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segmentation | Product, Application, End Use, Region |
| Companies Covered | Natus Medical Inc.; g.tec medical engineering GmbH; Medtronic; Compumedics Neuroscan; Brain Products GmbH; Integra Lifesciences Corp.; Advanced Brain Monitoring, Inc.; EMOTIV; NeuroSky; Interaxon, Inc.; ANT Neuro; Neuroelectrics; Ripple Neuro; NIRx Medical Technologies, LLC; OpenBCI; CGX; A Cognionics Company |
Product Insights
On basis of product, the market can be segmented into invasive, partially invasive, and non-invasive BCI. Non-invasive BCI held the largest revenue share of over 86.12% in 2021 owing to the high applicability of this technology to products, such as headsets, amplifiers, and gaming sticks, contributing to the massive revenue generation. This system is considered to be the safest as the approach is less intrusive, which is further fueling the segment growth. In addition, numerous research projects are going on in this field. For instance, in June 2019 Carnegie Mellon University in collaboration with the University of Minnesota developed the first-ever mind-controlled robotic arm using BCI technology, which can track and follow a computer cursor.
A product like this is anticipated to boost market growth in the foreseeable future. The invasive segment is expected to witness the fastest CAGR over the forecast period owing to the ability of this technology to provide the functionality to paralyzed people through brain-controlled robotic legs & arms and restore vision by connecting the brain to an external camera. The invasive device is positioned in the grey matter and is prone to building up scar tissue. Partially invasive BCI is also expected to show significant growth over the forecast period owing to its easy adaptability and various technological advancements. For instance, in September 2019, Synchron Inc. launched Stentrode, a partially invasive neural interface technology to record brain activities wirelessly.
Application Insights
On basis of application, the market has been segmented into healthcare, smart home control, communication & control, and entertainment & gaming. The healthcare segment captured the largest revenue share of more than 62.06% in 2021 owing to the high applicability of this technology in the treatment of sleep disorders, neurological diseases, paralytic patients, and in studying neuroscience. Moreover, technological advancement & increasing number of initiatives by the key industry players are further fueling the segment growth. For instance, in June 2018, Medtronic launched a new clinician programmer for deep brain stimulation therapy along with Activa (TM) Programming Application.
In October 2018, Advanced Brain Monitoring Inc. received a grant from the National Institute on Aging to develop robot-assistive interventions in aging & dementia. The initiatives like these are contributing to the dominant share of the healthcare segment. The smart home control segment is projected to witness a lucrative CAGR due to increased demand for a better lifestyle. With smart home controls, people are experiencing better convenience and comfort right from security monitoring, operating entertainment systems & appliances to maintaining connectivity. The aforementioned factors are expected to propel the segment growth over the forecast period.
End-use Insights
On basis of end uses, the global market has been further segmented into medical, military, and others. The medical end-use segment dominated the market in 2021 and accounted for the maximum share of more than 45.82% of the global revenue owing to its application in assisting disabled patients. The BCI technology assists in the movement of patients suffering from diseases, such as Parkinsonism, epilepsy, paralysis, and Alzheimer’s, to carry out activities independently, such as an operating wheelchair, prosthetics, and various other instruments.
The military end-use segment is expected to register the fastest growth rate over the forecast period on account of to increased usage of BCI during war activities. The development of mobile robots that can function as weapon-equipped drones in war zones and advanced communication systems, such as Defense Advanced Research Projects Agency’s (DARPA) “Silent Talk”, which would enable soldiers and military personnel to give commands via telepathic communication, is anticipated to contribute to the growth of this segment.
Regional Insights
North America accounted for the largest revenue share of more than 40.21% in 2021, primarily due to the high R&D investments and a large number of clinical trials being conducted on brain devices in this region. In addition, the rising incidence of neurodegenerative conditions, such as Parkinson’s, Alzheimer’s, and Huntington’s disease in this region are expected to propel market growth. In addition, the rising demand for immersive gaming is expected to lead to the development of technologies, such as augmented brain-computer interfaces that further boost the adoption of BCI technology in this region.
The market in the Asia Pacific region is expected to exhibit the fastest CAGR over the forecast period. Significant untapped opportunities; increasing healthcare expenditure, and growing awareness amongst patients are expected to drive the demand for BCIs in this region. Low-cost manufacturing sites and favorable taxation policies in these countries have attracted foreign players to invest in this lucrative market. Intensive R&D had led to the launch of many innovative products. For instance, in May 2018, Compumedics collaborated with China-based Health 100 to improve its product portfolio in sleep technology. In March 2019, Integra received approval for DuraGen Dural Regeneration Matrix in Japan, which helped in the company’s regional expansion.
Key Players
Market Segmentation
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Brain Computer Interface Market
5.1. COVID-19 Landscape: Brain Computer Interface Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Brain Computer Interface Market, By Product
8.1. Brain Computer Interface Market, by Product, 2022-2030
8.1.1 Invasive BCI
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Partially Invasive BCI
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Non-invasive BCI
8.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Brain Computer Interface Market, By Application
9.1. Brain Computer Interface Market, by Application, 2022-2030
9.1.1. Healthcare
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Disabilities Restoration
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Brain Function Repair
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Smart Home Control
9.1.4.1. Market Revenue and Forecast (2017-2030)
9.1.5. Communication & Control
9.1.5.1. Market Revenue and Forecast (2017-2030)
9.1.6. Entertainment & Gaming
9.1.6.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Brain Computer Interface Market, By End-use
10.1. Brain Computer Interface Market, by End-use, 2022-2030
10.1.1. Medical
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Military
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Others
10.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Brain Computer Interface Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Product (2017-2030)
11.1.2. Market Revenue and Forecast, by Application (2017-2030)
11.1.3. Market Revenue and Forecast, by End-use (2017-2030)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Product (2017-2030)
11.1.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.1.4.3. Market Revenue and Forecast, by End-use (2017-2030)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Product (2017-2030)
11.1.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.1.5.3. Market Revenue and Forecast, by End-use (2017-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product (2017-2030)
11.2.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.3. Market Revenue and Forecast, by End-use (2017-2030)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Product (2017-2030)
11.2.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.4.3. Market Revenue and Forecast, by End-use (2017-2030)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Product (2017-2030)
11.2.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.5.3. Market Revenue and Forecast, by End-use (2017-2030)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Product (2017-2030)
11.2.6.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.6.3. Market Revenue and Forecast, by End-use (2017-2030)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Product (2017-2030)
11.2.7.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.7.3. Market Revenue and Forecast, by End-use (2017-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product (2017-2030)
11.3.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.3. Market Revenue and Forecast, by End-use (2017-2030)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Product (2017-2030)
11.3.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.4.3. Market Revenue and Forecast, by End-use (2017-2030)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Product (2017-2030)
11.3.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.5.3. Market Revenue and Forecast, by End-use (2017-2030)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Product (2017-2030)
11.3.6.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.6.3. Market Revenue and Forecast, by End-use (2017-2030)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Product (2017-2030)
11.3.7.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.7.3. Market Revenue and Forecast, by End-use (2017-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product (2017-2030)
11.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.3. Market Revenue and Forecast, by End-use (2017-2030)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Product (2017-2030)
11.4.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.4.3. Market Revenue and Forecast, by End-use (2017-2030)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Product (2017-2030)
11.4.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.5.3. Market Revenue and Forecast, by End-use (2017-2030)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Product (2017-2030)
11.4.6.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.6.3. Market Revenue and Forecast, by End-use (2017-2030)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Product (2017-2030)
11.4.7.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.7.3. Market Revenue and Forecast, by End-use (2017-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product (2017-2030)
11.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.5.3. Market Revenue and Forecast, by End-use (2017-2030)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Product (2017-2030)
11.5.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.5.4.3. Market Revenue and Forecast, by End-use (2017-2030)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Product (2017-2030)
11.5.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.5.5.3. Market Revenue and Forecast, by End-use (2017-2030)
Chapter 12. Company Profiles
12.1. Natus Medical Incorporated
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. g.tec medical engineering GmbH
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Medtronic
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Compumedics Neuroscan
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Brain Products GmbH
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Integra Lifesciences Corporation
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Advanced Brain Monitoring, Inc.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. EMOTIV
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. NeuroSky
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Interaxon, Inc.
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers